288 related articles for article (PubMed ID: 28881141)
1. Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic Therapies.
Pitek AS; Wang Y; Gulati S; Gao H; Stewart PL; Simon DI; Steinmetz NF
Mol Pharm; 2017 Nov; 14(11):3815-3823. PubMed ID: 28881141
[TBL] [Abstract][Full Text] [Related]
2. Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage.
Pitek AS; Park J; Wang Y; Gao H; Hu H; Simon DI; Steinmetz NF
Nanoscale; 2018 Sep; 10(35):16547-16555. PubMed ID: 30137088
[TBL] [Abstract][Full Text] [Related]
3. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
[TBL] [Abstract][Full Text] [Related]
4. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
5. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.
McCarthy JR; Sazonova IY; Erdem SS; Hara T; Thompson BD; Patel P; Botnaru I; Lin CP; Reed GL; Weissleder R; Jaffer FA
Nanomedicine (Lond); 2012 Jul; 7(7):1017-28. PubMed ID: 22348271
[TBL] [Abstract][Full Text] [Related]
7. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
[TBL] [Abstract][Full Text] [Related]
8. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
10. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
Ma H; Jiang Z; Xu J; Liu J; Guo ZN
Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
[TBL] [Abstract][Full Text] [Related]
11. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
[TBL] [Abstract][Full Text] [Related]
12. Drug-Loaded Plant-Virus Based Nanoparticles for Cancer Drug Delivery.
Bruckman MA; Czapar AE; Steinmetz NF
Methods Mol Biol; 2018; 1776():425-436. PubMed ID: 29869258
[TBL] [Abstract][Full Text] [Related]
13. Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers.
Yu H; Palazzolo JS; Zhou J; Hu Y; Niego B; Pan S; Ju Y; Wang TY; Lin Z; Hagemeyer CE; Caruso F
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3740-3751. PubMed ID: 35019268
[TBL] [Abstract][Full Text] [Related]
14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
15. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
16. Is accelerated idioventricular rhythm a good marker for reperfusion after streptokinase?
Khan A; Nadeem S; Kokane H; Thummar A; Lokhandwala Y; Mahajan AU; Nathani PJ
Indian Heart J; 2016; 68(3):302-5. PubMed ID: 27316481
[TBL] [Abstract][Full Text] [Related]
17. Streptokinase--the drug of choice for thrombolytic therapy.
Kunamneni A; Abdelghani TT; Ellaiah P
J Thromb Thrombolysis; 2007 Feb; 23(1):9-23. PubMed ID: 17111203
[TBL] [Abstract][Full Text] [Related]
18. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
19. Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models.
Xu J; Zhang Y; Xu J; Liu G; Di C; Zhao X; Li X; Li Y; Pang N; Yang C; Li Y; Li B; Lu Z; Wang M; Dai K; Yan R; Li S; Nie G
Adv Mater; 2020 Jan; 32(4):e1905145. PubMed ID: 31788896
[TBL] [Abstract][Full Text] [Related]
20. Translational initiatives in thrombolytic therapy.
Klegerman ME
Front Med; 2017 Mar; 11(1):1-19. PubMed ID: 28116631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
